Luxor Capital Group’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,054
Closed -$85K 129
2022
Q1
$85K Buy
+14,054
New +$12.5K ﹤0.01% 105

Other funds holding CTV.WS

Luxor Capital Group's CTV.WS Position: Q1 2025 in Review

Luxor Capital Group sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2025, closing a stake of 13,853 shares — an estimated $1.38K sold.

Luxor Capital Group first reported a position in CTV.WS in Q4 2021 and held it in 12 quarters. The position peaked at $15K in Q4 2021. 1 fund tracked by Wall St. Rank holds CTV.WS as of Q1 2025.

  • Luxor Capital Group reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2025 after selling out during the quarter.
  • Luxor Capital Group sold 13,853 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2025, an estimated $1.38K.
  • Luxor Capital Group first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 12 quarters.
  • Luxor Capital Group's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $15K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2025.

Based on Luxor Capital Group's 13F filing for Q1 2025, filed 15 May 2025.